Expression of CD19++CD5++B cells and IgA1-positive cells in tonsillar tissues of IgA nephropathy patients

Renal Failure

Volumn 33, Issue 2, 2011, Pages 159-163

  Wu, Gang ^a   Peng, You Ming ^a   Liu, Hong ^a   Hou, Qi Di ^a   Liu, Fu You ^a   Chen, Nan Lan ^a   Bi, Hui Xin ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

CD19++CD5++B cells; IgA nephropathy; IgA1

Indexed keywords

CD19 ANTIGEN; CD5 ANTIGEN; IMMUNOGLOBULIN A1;

ADULT; ARTICLE; B LYMPHOCYTE; CHRONIC TONSILLITIS; CLINICAL ARTICLE; FEMALE; GERMINAL CENTER; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN A NEPHROPATHY; LYMPH NODE; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TONSIL; TONSIL CELL;

ADOLESCENT; ADULT; ANTIGENS, CD19; ANTIGENS, CD5; B-LYMPHOCYTES; CASE-CONTROL STUDIES; CHILD; FEMALE; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOGLOBULIN A; KIDNEY; MALE; MIDDLE AGED; PALATINE TONSIL; YOUNG ADULT;

EID: 79951990690     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2011.552150     Document Type: Article

References (23)

1. Donadio JV, Grande JP. IgA nephropathy. N Engl J Med. 2002;347:738-748. (Pubitemid 35203906)
2. Miura N, Imai H, Kikuchi S, et al. Tonsillectomy and steroid pulse (TSP) therapy for patients with IgA nephropathy: A nation-wide survey of TSP therapy in Japan and an analysis of the predictive factors for resistance to TSP therapy. Clin Exp Nephrol. 2009;13:460-466.
3. Fujinaga S, Ohtomo Y, Hirano D, et al. Low-dose pulse methylprednisolone followed by short-term combination therapy and tonsillectomy for childhood IgA nephropathy. Pediatr Nephrol. 2010;25:563-564.
4. Kataoka K, Fujihashi K, Sekine S, et al. Nasal cholera toxin elicits IL-5 and IL-5 receptor alpha-chain expressing B-1a B cells for innate mucosal IgA antibody responses. J Immunol. 2007;178:6058-6065. (Pubitemid 46717385)
5. Fagarasan S, Honjo T. T-independent immune response: New aspects of B cell biology. Science. 2000;290:89-92.
6. Kodama S, Suzuki M, Arita M, Mogi G. Increase in tonsillar germinal centre B-1 cell numbers in IgA nephropathy (IgAN) patients and reduced susceptibility to Fas-mediated apoptosis. Clin Exp Immunol. 2001 February; 123(2): 301-308. (Pubitemid 32174783)
7. Byian Duana and Laurence Morel. Role of B-1a cells in autoimmunity. Autoimmun Rev. 2006;5:403-408.
8. Richard R Hardy. B- 1 B cells: Development, selection, natural autoantibody and leukemia. Curr Opin Immunol. 2006;18:547-555.
9. McCarthy DD, Chiu S, Gao Y, Summers-deLuca LE, Gommerman JL. BAFF induces a hyper-IgA syndrome in the intestinal lamina propria concomitant with IgA deposition in the kidney independent of LIGHT. Cell Immunol. 2006;241:85-94. (Pubitemid 44649295)
10. Kodama S, Suzuki M, Arita M, Mogi G. Increase in tonsillar germinal centre B-1 cell numbers in IgA nephropathy (IgAN) patients and reduced susceptibility to Fas-mediated apoptosis. Clin Exp Immunol. 2001;123:301-308. (Pubitemid 32174783)
11. Lee HS, Lee MS, Lee SM, et al. Histological grading of IgA nephropathy predicting renal outcome: Revisiting H.S. Lee's glomerular grading system. Nephrol Dial Transplant. 2005;20(2):342-348. (Pubitemid 40276890)
12. Montecino-Rodriguez E, Dorshkind K. New perspectives in B-1 B cell development and function. Trends Immunol. 2006;27:428-433. (Pubitemid 44216193)
13. Hayakawa K, Hardy RR. Development and function of B-1 cells. Curr Opin Immunol. 2000;12:346-354. (Pubitemid 30240547)
14. Su I, Tarakhovsky A. B-1 cells: Orthodox or conformist? Curr Opin Immunol. 2000;12:191-194.
15. Berland R, Wortis HH. Origins and functions of B-1 cells with notes on the role of CD5. Annu Rev Immunol. 2002;20:253-300. (Pubitemid 34293426)
16. Haas KM, Poe JC, Steeber DA, Tedder TF. B- 1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae. Immunity. 2005;23:7-18. (Pubitemid 41019653)
17. Hiroi T, Yanagita M, Iijima H, et al. Deficiency of IL-5 receptor α-chain selectively influences the development of the common mucosal immune system independent IgA-producing B-1 cell in mucosa-associated tissues. J Immunol. 1999;162:821-828. (Pubitemid 29035405)
18. Nossal GJV, Karvelas M, Pulendran B. Soluble antigen profoundly reduces memory B-cell numbers even when given after challenge immunization. Proc Natl Acad Sci USA. 1993;90:3088-3094.
19. Itoh A. Disordered balance of IgA subclass production in the tonsils of some IgA nephropathy patients. J Nephrol. 2005;18(5):575-581. (Pubitemid 41824478)
20. Cioca DP. Apoptosis induction by hypercross-linking of the surface antigen CD5 with anti-CD5 monoclonal antibodies in B cell chronic lymphocytic leukemia. Leukemia. 2002;16(3):335.
21. Pers JO. CD5-induced apoptosis of B cells in some patients with chronic lymphocytic leukemia. Leukemia. 2002;16(1):44.
22. Macpherson A, Gatto D, Sainsbury E, Harriman GR, Hengartner H, Zinkernagel RM. A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science. 2000;288:2222-2226. (Pubitemid 30429609)
23. Yuling H, Ruijing X, Xiang J, et al. CD19+CD5+B cells in primary IgA nephropathy. J Am Soc Nephrol. 2008;19(11):2130-2139.